| P/E (FY) | — | Sales (TTM) | $4.7M |
| Earnings (TTM) | -$90.3M | ROE | — |
| Net Margin | −1106.72% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $181.1M | Trading Days | 1360 |
| 52W High | 13.69 |
| 52W Low | 3.98 |
| % Off High | −68.95% |
| YTD | −54.40% | 1Y | −51.48% |
| 3Y | −80.68% | 5Y | −98.91% |
| Since incept. (ann.) | −61.26% |
| Ann. Volatility (1Y) | 82.28% | Ann. Volatility (3Y) | 104.77% |
| Sharpe (1Y) | −0.48 | Sharpe (3Y) | −0.02 |
| Max Drawdown (1Y) | −69.31% | Max Drawdown (3Y) | −91.25% |
| Beta (3Y, vs SPY) | 2.52 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| IVVD | Invivyd, Inc. | $179.7M | — |
| CRIS | CURIS INC | $182.8M | — |
| LENZ | LENZ Therapeutics, Inc. | $178.7M | — |
| BCDA | BioCardia, Inc. | $186.1M | — |
| VYGR | Voyager Therapeutics, Inc. | $186.7M | — |
| ACOG | Alpha Cognition Inc. | $186.8M | — |
| DTIL | PRECISION BIOSCIENCES INC | $187.1M | — |
| PLX | Protalix BioTherapeutics, Inc. | $193.4M | — |
| ALEC | Alector, Inc. | $167.6M | — |
| TNYA | Tenaya Therapeutics, Inc. | $167.0M | — |
| BCAB | BioAtla, Inc. | $200.0M |
| CRBU | Caribou Biosciences, Inc. | $157.7M | — |
